AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ArcticZymes Technologies

Transaction in Own Shares Nov 28, 2025

3538_rns_2025-11-28_e3bed432-7f1c-4cb3-ac28-00002e8dcccb.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purchase Program

ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purchase Program

Tromsø, Norway, November 28th, 2025 - Reference is made to the stock exchange

announcement published by ArcticZymes Technologies ASA (the "Company", OSE: AZT)

on 25 November 2025 announcing the initiation of a share buyback program

pursuant to the authorization granted by the Annual General Meeting held on 27

May 2025.

The share buyback program has now been completed. From and including 25 November

2025 to and including 28 November 2025, the Company has purchased a total of

31,365 own shares at an average price of NOK 22.5037 per share. Please see the

attached table for further details.

Following completion of the program, the Company holds 31,365 own shares, equal

to approx. 0.061 per cent of the total number of shares in the Company.

The repurchased shares will be used to settle obligations under the share-based

incentive programs for employees and management where employees can acquire

shares at 15% discount to the market price.

This information is made public pursuant to the EU Market Abuse Regulation and

subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian

Securities Trading Act.

For more information, please contact:

ArcticZymes Technologies ASA

CEO, Michael B. Akoh Tel: +46 (0) 70 262 37 15

CFO, Børge Sørvoll Tel +47 952 90187

[email protected]

About ArcticZymes Technologies ASA

Headquartered in Tromsø, Norway, ArcticZymes Technologies ASA is a publicly

listed, leading provider of novel and high-quality enzymes for use in molecular

research, diagnostics, and biomanufacturing. With over 30 years of expertise,

the company develops and manufactures salt-active nucleases and other specialty

enzymes inspired by the Arctic environment, enabling robust performance under

demanding process conditions. ArcticZymes is certified to ISO 13485 and

manufactures under relevant ICH GMP standards.

For more information, visit www.arcticzymes.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.